Today Unite Us, a leading software company enabling cross-sector collaboration to improve people’s health and well-being, announced a partnership with Healthix, the largest public health information exchange (HIE) in the nation serving New York City and Long Island.
Healthix and Unite Us will provide technology to enable communication between healthcare systems and social care networks. Together, they aim to address social drives of health such as food, housing, transportation assistance, and more.
Unite Us and Healthix are already collaborating in large social care networks with Public Health Solutions, which provides critical resources directly to New York City’s most underserved populations.
AstraZeneca brushed off a news report that longtime CEO Pascal Soriot plans to leave the company. British tabloid The Daily Mail on Sunday had reported
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional
COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has entered
Unite Us Partners with Healthix and Regional Social Care Networks
by Jasmine Pennic Leave a Comment
What You Should Know:
AstraZeneca addresses report that CEO Pascal Soriot plans to depart
AstraZeneca brushed off a news report that longtime CEO Pascal Soriot plans to leave the company. British tabloid The Daily Mail on Sunday had reported
Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation – Biotech Investments
EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional
COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors | Psychedelic Invest
COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has entered